Hanna Abuhay is a Cancer Research Training Fellow (CRTA) in the Healthcare Delivery Research Program’s Outcomes Research Branch (ORB). As a CRTA, Hanna will be working with Dr. Sandra Mitchell, providing support for projects related to the dissemination, implementation, and interpretation of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAETM). She will also be supporting projects related to clinical decision support for cancer symptom management, including guidelines for cancer-related fatigue management.
Hanna received a Bachelor of Science from the University of California, Santa Cruz, with a focus on Molecular, Cell, and Developmental Biology. Prior to joining HDRP, Hanna was an IRTA fellow in the Laboratory of Allergy Disease in the National Institute of Allergy and Infectious Diseases (NIAID). At NIAID, she studied the perceived risk for adverse reactions to vaccines in children with cutaneous or systemic mastocytosis, and contributed to efforts to better characterize maculopapular cutaneous mastocytosis in diverse populations.